{
    "title": "U.S. strikes deal with Lilly for potential COVID-19 antibody drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8888243/Eli-Lilly-supply-U-S-300-000-vials-potential-COVID-19-drug.html",
    "date": "2020-10-28",
    "keywords": [
        "drug",
        "government",
        "antibody",
        "treatment",
        "use",
        "covid19",
        "emergency",
        "authorization",
        "health",
        "company",
        "statement",
        "regeneron",
        "deal",
        "president",
        "regulator",
        "option",
        "department",
        "human",
        "officer",
        "david",
        "companys",
        "website",
        "dose",
        "discount",
        "rick",
        "purchase",
        "supply",
        "spread",
        "virus",
        "activity",
        "return",
        "end",
        "astrazeneca",
        "trump",
        "operation",
        "speed",
        "program",
        "cost",
        "astrazenecas",
        "latestage",
        "support",
        "development",
        "request",
        "food",
        "administration",
        "month",
        "setback",
        "success",
        "addition",
        "quality",
        "control",
        "lilly",
        "plant",
        "therapy",
        "reporting",
        "bengaluru",
        "editing",
        "bernard",
        "orr",
        "saumyadeb",
        "chakrabarty"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}